Partnering

4basebio UK Societas is seeking to establish and nurture collaborations and partnership with a view to deploy 4basebio technologies and products for delivery of clinically relevant payloads across a variety of different applications and therapies including gene replacement, gene editing, gene vaccines enzyme replacement and a variety of cell therapies. 

Hermes^TM, our proprietary non-viral gene delivery system is fully compatible with all types of biological payloads such as protein, RNA and DNA, including of course hpDNA^TM. Furthermore, our DNA products and technologies are also suitable for all other types of viral or non-viral gene delivery platforms. 

In addition to industrial and commercial partnerships, 4basebio is actively seeking to collaborate with, and or licence from, academics working on potential gene therapy candidates and novel delivery systems.